Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Edgar L. Ross"'
Publikováno v:
PAIN Reports, Vol 4, Iss 3, p e747 (2019)
Abstract. Introduction:. Chronic pain patients frequently report having sleep disturbances and many tend to stay up during the night and then sleep into the day. Objectives:. This study was designed to compare a heterogeneous group of persons with ch
Externí odkaz:
https://doaj.org/article/43db93d8fadb4c7ca03085fc2ed908b6
Autor:
Limeng Wan, Robert N. Jamison, Samantha Curran, Christopher J. Gilligan, Edgar L. Ross, Robert R. Edwards
Publikováno v:
Neuromodulation: Technology at the Neural Interface. 25:1410-1420
Objectives This study investigated the efficacy of a transcutaneous electrical nerve stimulation (TENS) device (Quell®) for persons with symptoms due to fibromyalgia (FM). Materials and methods One hundred nineteen (N = 119) subjects were randomly a
Autor:
Marc Russo, ReActiv B investigators, Kristiaan Deckers, Jean-Pierre Van Buyten, Sam Eldabe, Jan Pieter Heemels, Eugene Mironer, Christopher J. Gilligan, Richard Rauck, Jonathan Gentile, Kris De Smedt, B. Mitchell, Vikas V. Patel, Matthew Green, Christopher A. Gilmore, Ganesan Baranidharan, Farshad M. Ahadian, Peter Georgius, Alexios G. Carayannopoulos, Antoine Tohmeh, Usman Latif, Jeffrey S. Fischgrund, Willem Volschenk, Salim M. Hayek, Robert Levy, Vivek Mehta, Shivanand P. Lad, James P. Rathmell, Timothy R. Deer, Ashish Gulve, William R. Klemme, Edgar L. Ross, Frank J P M Huygen, Meredith Langhorst
Publikováno v:
Pain, 162(10), 2486-2498. Lippincott Williams & Wilkins
Chronic low back pain can be caused by impaired control and degeneration of the multifidus muscles and consequent functional instability of the lumbar spine. Available treatment options have limited effectiveness and prognosis is unfavorable. We cond
Autor:
Robert N. Jamison, Shai N. Gozani, Christopher J. Gilligan, Limeng Wan, Samantha Curran, Edgar L. Ross, Robert R. Edwards
Publikováno v:
Journal of Pain Research
Robert N Jamison,1 Robert R Edwards,1 Samantha Curran,1 Limeng Wan,1 Edgar L Ross,1 Christopher J Gilligan,1 Shai N Gozani2 1Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham & Womenâs Hospital, Chest
Publikováno v:
Pain Physician. :243-252
Background: Control of chronic pain and mainly the partial or complete loss of response to analgesics is a major unmet need. Multiple mechanisms underline the development of tolerance to analgesics in general and specifically to opioids. The autonomi
Autor:
Ryan K. Lanier, Deryk G. Jones, Dennis C. Turk, Nathaniel P. Katz, Edgar L. Ross, Scott Kelley, Andrew I. Spitzer, Joelle Lufkin, Philip G. Conaghan, Alan Kivitz, Amy Cinar
Publikováno v:
Pain and therapy. 11(1)
A phase 3 randomized controlled study comparing triamcinolone acetonide extended-release (TA-ER) to conventional TA crystalline suspension (TAcs) reported variable efficacy results. Enrollment criteria may have contributed to this discrepancy, as mod
Publikováno v:
The Journal of Pain. 20:278-287
This study compared persons with chronic pain who consistently reported that their pain was worsening with those who reported that their pain was improving or remaining the same per daily assessment data from a smartphone pain app. All participants c
Publikováno v:
Pain Practice. 19:466-475
OBJECTIVE This controlled trial examined the benefit of a high-frequency transcutaneous electrical nerve stimulation (hfTENS) device (the Quell, NeuroMetrix, Inc., Waltham, MA, U.S.A.) for patients with chronic low back pain (CLBP). METHODS Thirty-fi
Publikováno v:
JMIR Diabetes
JMIR Diabetes, Vol 5, Iss 4, p e20532 (2020)
JMIR Diabetes, Vol 5, Iss 4, p e20532 (2020)
Background Type 2 diabetes mellitus (T2DM) is an international problem of alarming epidemic proportions. T2DM can develop due to multiple factors, and it usually begins with prediabetes. Fortunately, this disease can be prevented by following a healt
Autor:
Ashish Bhandari, Patrick W. Mantyh, Edgar L. Ross, Jason D. Ross, Tony L. Yaksh, Roshni Ramachandran
Publikováno v:
Future Drug Discovery. 2
Opioids have long been the mainstay of cancer pain treatment and have been used without any consideration for their effect on cancer growth and long-term prognosis. There is now growing evidence that the continued use of opioids for this indication s